Atomic Alchemy Isotope Platform

Early Commercialization

Overview

Oklo's isotope business combines the Idaho Radiochemistry Laboratory, a planned pilot reactor in Texas, and a future multi-reactor foundry to supply critical medical, industrial, research, defense, and space isotopes.

A March 2026 NRC materials license enables initial commercial sales from Idaho, while Oklo advances its Groves isotope pilot reactor and longer-term VIPR foundry plans.

Key Specs

NRC License

Granted March 2026

Initial Sales

Idaho Radiochemistry Laboratory

Foundry Plan

Up to 4 VIPR reactors

VIPR Capacity

~15 MWth each